Clinical trials
Completed trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,810 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 8 |
| 2001 | 26 |
| 2002 | 19 |
| 2003 | 44 |
| 2004 | 36 |
| 2005 | 69 |
| 2006 | 76 |
| 2007 | 62 |
| 2008 | 86 |
| 2009 | 76 |
| 2010 | 102 |
| 2011 | 81 |
| 2012 | 102 |
| 2013 | 107 |
| 2014 | 94 |
| 2015 | 112 |
| 2016 | 84 |
| 2017 | 95 |
| 2018 | 83 |
| 2019 | 77 |
| 2020 | 81 |
| 2021 | 85 |
| 2022 | 71 |
| 2023 | 41 |
| 2024 | 33 |
| 2025 | 19 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,810 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 120 |
| GlaxoSmithKline | 79 |
| Gilead Sciences | 73 |
| Boehringer Ingelheim | 67 |
| Children's Oncology Group | 63 |
| AbbVie | 41 |
| Amgen | 32 |
| Merck Sharp & Dohme LLC | 32 |
| University of Auckland, New Zealand | 32 |
| Novartis Pharmaceuticals | 31 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 58 |
| Hepatitis B, Chronic | 57 |
| Hepatitis C | 54 |
| Pulmonary Disease, Chronic Obstructive | 53 |
| Arthritis, Rheumatoid | 45 |
| Breast Neoplasms | 42 |
| Coronary Artery Disease | 40 |
| Asthma | 39 |
| Neoplasms | 34 |
| Cardiovascular Diseases | 33 |
Trials
Showing 1 to 25 of 1,810. Each trial links to its page on Pharma Observatory.
1,710 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.